In the U.S., rates of multidrug-resistant tuberculosis remain low, but are starting to inch back up, as hundreds of millions of American citizens and foreigners alike travel to the U.S. from abroad every year. At the same time, funding and expertise are in decline.
TB's global resurgence amplifies U.S. risk
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.